Skip to main content
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.794
+0.003 (0.34%)
At close: Apr 28, 2026, 4:00 PM EDT
0.794
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

aTyr Pharma Revenue

In the year 2025, aTyr Pharma had annual revenue of $190.00K, down -19.15%.

Revenue (ttm)
$190.00K
Revenue Growth
-19.15%
P/S Ratio
408.15
Revenue / Employee
$3,167
Employees
60
Market Cap
77.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025190.00K-45.00K-19.15%
Dec 31, 2024235.00K-118.00K-33.43%
Dec 31, 2023353.00K-10.03M-96.60%
Dec 31, 202210.39M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ImmuCell 27.64M
Pelthos Therapeutics 16.80M
TScan Therapeutics 10.33M
Alterity Therapeutics 4.43M
Seres Therapeutics 789.00K
Revenue Rankings

ATYR News

More News